Factors affecting costs and utilization of type 2 diabetes healthcare: A cross-sectional survey among 15 hospitals in urban China

BMC Health Services Research

Volumn 10, Issue , 2010, Pages

  Wang, Weibing ^a   Fu, Chaowei ^a   Zhuo, Haijing ^b   Luo, Jianfeng ^a   Xu, Biao ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHINA; COST OF ILLNESS; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; HOSPITAL; HUMAN; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; UTILIZATION REVIEW;

CHINA; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALS, URBAN; HUMANS; MALE; MULTIVARIATE ANALYSIS;

EID: 77955672046     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-244     Document Type: Review

References (34)

1. International Diabetes Federation, Diabetes atlas Brussels: IDF 3 2006
2. Prevalence of diabetes among men and women in China. W Yang J Lu J Weng W Jia L Ji J Xiao Z Shan J Liu H Tian Q Ji, et al. N Engl J Med 2010 362 12 1090 1101 10.1056/NEJMoa0908292 20335585
3. Report on Chronic Disease in China. X Qi Y Wang, Beijing: China National Center for Disease Control and Prevention 2006
4. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. S Wild G Roglic A Green R Sicree H King, Diabetes Care 2004 27 5 1047 1053 10.2337/diacare.27.5.1047 15111519
5. DT Jamison World Bank., Disease Control Priorities Project, Disease control priorities in developing countries New York & Washington, DC: Oxford University Press; World Bank 2 2006
6. How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? W Wang CW Fu CY Pan W Chen S Zhan R Luan A Tan Z Liu B Xu, Value Health 2009 12 6 923 929 10.1111/j.1524-4733.2009.00561.x 19824187
7. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. JB Brown GA Nichols HS Glauber AW Bakst, Diabetes Care 1999 22 7 1116 1124 10.2337/diacare.22.7.1116 10388977
8. Assessing the impact of complications on the costs of Type II diabetes. R Williams L Van Gaal C Lucioni, Diabetologia 2002 45 7 13 17 12136406
9. The direct medical cost of type 2 diabetes. M Brandle H Zhou BR Smith D Marriott R Burke BP Tabaei MB Brown WH Herman, Diabetes Care 2003 26 8 2300 2304 10.2337/diacare.26.8.2300 12882852
10. The cost to health plans of poor glycemic control. TP Gilmer PJ O'Connor WG Manning WA Rush, Diabetes Care 1997 20 12 1847 1853 10.2337/diacare.20.12. 1847 9405905
11. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. UK Prospective Diabetes Study Group, Lancet 1998 352 9131 837 853 10.1016/S0140-6736(98)07019- 6 9742976
12. Predictors of health care costs in adults with diabetes. TP Gilmer PJ O'Connor WA Rush AL Crain RR Whitebird AM Hanson LI Solberg, Diabetes Care 2005 28 1 59 64 10.2337/diacare.28.1.59 15616234
13. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. DP Goldman GF Joyce Y Zheng, JAMA 2007 298 1 61 69 10.1001/jama.298.1.61 17609491
14. Out-of-pocket expenses and healthcare resource utilization among individuals with or at risk of diabetes mellitus. KM Fox SG Group, Curr Med Res Opin 2008 24 12 3323 9 10.1185/03007990802520045 18954500
15. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. BA Young E Lin M Von Korff G Simon P Ciechanowski EJ Ludman S Everson-Stewart L Kinder M Oliver EJ Boyko, et al. Am J Manag Care 2008 14 1 15 23 18197741
16. Factors affecting health-care costs and hospitalizations among diabetic patients in Thai public hospitals. U Chaikledkaew P Pongchareonsuk N Chaiyakunapruk B Ongphiphadhanakul, Value Health 2008 11 Suppl 1 69 74 10.1111/j.1524-4733.2008.00369.x 18387070
17. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population. DM Hartung MJ Carlson DF Kraemer DG Haxby KL Ketchum MR Greenlick, Med Care 2008 46 6 565 572 10.1097/MLR.0b013e3181734a77 18520310
18. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. KG Alberti PZ Zimmet, Diabet Med 1998 15 7 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2- S 9686693
19. Cost of Type 2 Diabetes mellitus in Hong Kong Chinese. BS Chan MW Tsang VW Lee KK Lee, Int J Clin Pharmacol Ther 2007 45 8 455 468 17725179
20. Prescription drug use and costs among diabetic patients in primary health care practices in Germany. W Rathmann B Haastert JM Roseman FA Gries G Giani, Diabetes Care 1998 21 3 389 397 10.2337/diacare.21.3.389 9540021
21. [Costs of type 2 diabetes in Germany. Results of the CODE-2 study]. A Liebl A Neiss A Spannheimer U Reitberger T Wagner A Gortz, Dtsch Med Wochenschr 2001 126 20 585 589 10.1055/s-2001-14102 11402924
22. Economic costs of diabetes in the U.S. In 2007. American-Diabetes- Association, Diabetes Care 2008 31 3 596 615 10.2337/dc08-9017 18308683
23. Moral hazard and consumer-driven health care: a fundamentally flawed concept. JP Geyman, Int J Health Serv 2007 37 2 333 351 10.2190/J354-150M-NG76- 7340 17665727
24. Urban health insurance reform and coverage in China using data from National Health Services Surveys in 1998 and 2003. L Xu Y Wang CD Collins S Tang, BMC Health Serv Res 2007 7 37 10.1186/1472-6963-7-37 17335584
25. Use of health care services by lower-income and higher-income uninsured adults. JS Ross EH Bradley SH Busch, JAMA 2006 295 17 2027 2036 10.1001/jama.295.17.2027 16670411
26. Health insurance coverage and the use of preventive services by Mexican adults. JA Pagan A Puig BJ Soldo, Health Econ 2007 16 12 1359 1369 10.1002/hec.1226 17334977
27. Study on National Health Services in 2003. Ministry of Health, Beijing: Ministry of Health, China 2004
28. A study on New Cooperative Medical Scheme in China. Y Zuo S Hu W Fu, Chinese Health Resources 2006 9 3 127 129
29. China national health accounts report 2005. China National Health Economics Institute, Beijing: China National Health Economics Institute 2005
30. Reform of how health care is paid for in China: challenges and opportunities. S Hu S Tang Y Liu Y Zhao ML Escobar D de Ferranti, Lancet 2008 372 9652 1846 1853 10.1016/S0140-6736(08)61368-9 18930520
31. Urban employee health insurance reform and the impact on out-of-pocket payment in China. GG Liu Z Zhao, Int J Health Plann Manage 2006 21 3 211 228 10.1002/hpm.846 17044547
32. Tracking China's health reform. Y Guo K Shibuya G Cheng K Rao L Lee S Tang, Lancet 2010 375 9720 1056 1058 10.1016/S0140-6736(10)60397-2 20346797
33. A Summary Analysis and some Policy Suggestion of the Flows of Total Health Expenditure in China. L Du, Chinese Health Economics 2008 299 1 19 20
34. Effect of improved glycemic control on health care costs and utilization. EH Wagner N Sandhu KM Newton DK McCulloch SD Ramsey LC Grothaus, JAMA 2001 285 2 182 189 10.1001/jama.285.2.182 11176811